← Back to Patent Explorer
US4564596A Expired / Lapsed US ⏱️ 0.0 years remaining

Urokinase derivatives covalently bound to fibrinogen

Assignee: VSESOJUZNY KARDIOLOGICHESKY NAUCHNY TSENTR AKADEMII MEDITSINSKIKH NAUK SSSR USSR MOSCOW 3 CHEREPKOVSKAYA ULITSA 15A
•
Filing: 1984-03-01
•
Granted: 1986-01-14
•
Expires: 2004-03-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Urokinase derivatives comprise urokinase covalently bonded with fibrinogen or urokinase covalently bonded with fibrinogen through an aliphatic diamine and correspond to the general formula: ##STR1## wherein P is fibrinogen, E is urokinase, R is absent or stands for ##STR2## wherein n is 1-12, with a molecular mass of from 360,000 to 440,000 D, a content of protein of 10 to 30% by mass, an esterase catalytic activity of 30-60%. These derivatives have an increased affinity to fibrin and feature a prolonged fibrinolytic effect.

Inventors

  • 👤 Alexandr V. Maximenko
  • 👤 Elena G. Tischenko
  • 👤 Vladimir P. Torchilin
  • 👤 Vladimir N. Smirnov
  • 👤 Evgeny I. Chazov

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:04
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6462; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61P; A61P7/00; A61P7/02; C12N9/96; C12Y; C12Y304/00; C12Y304/21; C12Y304/21073; A61K38/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 67 words
Urokinase derivatives comprising urokinase covalently bonded with fibrinogen or urokinase covalently bonded, through an aliphatic diamine, with fibrinogen of the general formula: ##STR6## wherein P is fibrinogen, E is urokinase, R is either a single bond or stands for ##STR7## wherein n is 1-12, with a molecular mass of 360,000 to 440,000D, a content of protein of 10-30% by mass, and an esterase catalytic activity of 30-60%.
Claim 2
Dependent Claim 67 words
Urokinase derivatives comprising urokinase covalently bonded with fibrinogen or urokinase covalently bonded, through an aliphatic diamine, with fibrinogen of the general formula: ##STR6## wherein P is fibrinogen, E is urokinase, R is either a single bond or stands for ##STR7## wherein n is 1-12, with a molecular mass of 360,000 to 440,000D, a content of protein of 10-30% by mass, and an esterase catalytic activity of 30-60%.
Claim 3
Dependent Claim 12 words
The urokinase derivative of claim 1 wherein said aliphatic diamine is 1,12-dodecamethylenediamine.
Claim 4
Dependent Claim 12 words
The urokinase derivative of claim 1 wherein said aliphatic diamine is 1,10-decamethylenediamine.
Claim 5
Dependent Claim 12 words
The urokinase derivative of claim 1 wherein said aliphatic diamine is 1,7-heptamethylenediamine.
Claim 6
Dependent Claim 12 words
The urokinase derivative of claim 1 wherein said aliphatic diamine is 1,4-tetramethylenediamine.
Claim 7
Dependent Claim 12 words
The urokinase derivative of claim 1 wherein R represents a single bond.
Claim 8
Dependent Claim 85 words
A process for the preparation of a urokinase derivative of the formula: ##STR8## which comprises reacting a compound of the formula: ##STR9## with a compound of the formula: ##STR10## wherein P is fibrinogen, E is urokinase, R represents a single bond or ##STR11## R 1 is C 2 H 5 , R 2 is ##STR12## and n is 1-12, and recovering said derivative having a molecular mass of 360,000 to 440,000D, a protein content of 10-30% by mass, and an esterase catalytic activity of 30-60%.
Claim 9
Dependent Claim 85 words
A process for the preparation of a urokinase derivative of the formula: ##STR8## which comprises reacting a compound of the formula: ##STR9## with a compound of the formula: ##STR10## wherein P is fibrinogen, E is urokinase, R represents a single bond or ##STR11## R 1 is C 2 H 5 , R 2 is ##STR12## and n is 1-12, and recovering said derivative having a molecular mass of 360,000 to 440,000D, a protein content of 10-30% by mass, and an esterase catalytic activity of 30-60%.

References Cited (Backward Citations)

US3544427A Cited
US4029767A Cited
US4011142A Cited
JPS54113488A Cited
US4244943A Cited
US4286063A Cited
US4349630A Cited
SU1022988A1 Cited
US4381346A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-01-13 1989-07-15 1990-01-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-01-13 1993-07-15 1994-01-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-01-13 1997-07-15 1998-01-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag